TD Asset Management’s Twist Bioscience TWST Stock Holding History

TD Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.7M	Buy	103,986 +97,610	+1,531%	+$6.35M	0.01%	641
2026 Q1	$303K	Buy	+6,376	New	+$286K	﹤0.01%	1205
2023 Q4	–	Sell	-73,148	Closed	-$1.48M	–	1443
2023 Q3	$1.48M	Buy	73,148 +42,374	+138%	+$931K	﹤0.01%	1044
2023 Q2	$630K	Buy	30,774 +900	+3%	+$13.5K	﹤0.01%	1220
2023 Q1	$451K	Hold	29,874	–	–	﹤0.01%	1281
2022 Q4	$711K	Sell	29,874 -6,100	-17%	-$177K	﹤0.01%	1211
2022 Q3	$1.29M	Hold	35,974	–	–	﹤0.01%	1123
2022 Q2	$1.26M	Hold	35,974	–	–	﹤0.01%	1135
2022 Q1	$1.78M	Buy	35,974 +8,173	+29%	+$453K	﹤0.01%	1120
2021 Q4	$2.15M	Sell	27,801 -5,400	-16%	-$554K	﹤0.01%	1110
2021 Q3	$3.55M	Hold	33,201	–	–	﹤0.01%	915
2021 Q2	$4.08M	Hold	33,201	–	–	﹤0.01%	883
2021 Q1	$4.11M	Buy	33,201 +1,189	+4%	+$181K	﹤0.01%	886
2020 Q4	$4.52M	Buy	32,012 +6,704	+26%	+$744K	0.01%	817
2020 Q3	$1.92M	Hold	25,308	–	–	﹤0.01%	921
2020 Q2	$1.15M	Buy	+25,308	New	+$908K	﹤0.01%	1024

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

TD Asset Management's TWST Position: Q2 2026 in Review

TD Asset Management increased its Twist Bioscience (TWST) stake by 1,531% in Q2 2026, buying an estimated $6.35M and bringing the position to 103,986 shares worth $10.7M. The position accounts for 0.01% of the portfolio, ranked #641.

TD Asset Management first reported a position in TWST in Q2 2020 and has held it in 16 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

TD Asset Management held 103,986 shares of Twist Bioscience worth $10.7M as of Q2 2026.
TD Asset Management bought 97,610 Twist Bioscience shares in Q2 2026, an estimated $6.35M.
Twist Bioscience made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #641 holding.
TD Asset Management first reported a position in Twist Bioscience in Q2 2020 and has held it in 16 quarters since.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.